(GSK) GlaxoSmithKline – Bear of the Day

February 1st, 2010

GlaxoSmithKline (GSK) reported third quarter income of $0.92 per American Depositary Share (ADS), 3 cents below the Zacks Consensus Estimate. The company reported earnings of $0.94 in the year-ago period.

Third quarter revenue increased 3%. While the company’s diversified base and presence in different geographical areas should help support revenues, we remain concerned about future growth prospects given the patent challenges being faced by several of Glaxo’s products. With several products expected to lose exclusivity and the swine flu opportunity likely to miss expectations, we expect the company’s topline to remain under pressure in the coming quarters.

Glaxo’s pipeline needs to deliver in order to make up for lost revenues and any development or regulatory setbacks would be a major disappointment for the company. We have downgraded the stock to Underperform with a target price of $37.

Zacks Investment Research

More on this topic (What's this?)
Biota (Fusion Investing and Analysis, 1/19/10)
4 Undervalued Dividend Stocks To Buy, 1 To Avoid (Investment Underground » Page n..., 1/16/12)
Stock Market News: Citigroup (NYSE:C), GlaxoSmithKline (NYSE:GSK), JPMorgan (NYSE:JPM) (Jutia Group, 2/15/10)
FDA Approves Glaxo’s (NYSE: GSK) Cervical Cancer Vaccine (, 10/16/09)
Read more on GlaxoSmithKline at Wikinvest

Related Posts:

  1. (GSK) GlaxoSmithKline Earns Positive Opinion From Te European Medicines AgencyLast week, GlaxoSmithKline (GSK) and Denmark-based Genmab received good news with the European Medicines Agency’s...
  2. (GSK) GlaxoSmithKline – Bear of the DayGlaxoSmithKline (GSK) reported third quarter income of $0.92 per American Depository Share (ADS), 3 cents...
  3. (GSK) Anti-Smoking Vaccine Offered by GlaxoSmithKlineGlaxoSmithKline (GSK) and Nabi Biopharmaceuticals (NABI) signed a licensing agreement for a nicotine conjugate vaccine...
  4. (GSK) GlaxoSmithKline Reports Higher RevenuesGlaxoSmithKline, plc (GSK) reported third quarter income of 92 cents per American Depository Share (ADS),...
  5. (GSK) GlaxoSmithKline Earns FDA Approval for Advanced Renal Cell Carcinoma TreatmentYesterday, GlaxoSmithKline (GSK) received some good news with the US Food and Drug Administration’s (FDA)...
  6. ($GSK) GlaxoSmithKline Announces Swine Flu Vaccine Orders IncreaseYesterday, GlaxoSmithKline (GSK) announced that orders for its pandemic (H1N1) adjuvanted vaccine have increased significantly...


Search Posts by Tag: | | Drug Manufacturers - Major | Healthcare

RSS Feeds by Tag: Glaxosmithkline plc | GSK | Drug Manufacturers - Major | Healthcare |

Other Posts by: | RSS Feed for this author